Novel bladder cancer treatment gains MHRA approval in the UK
Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) ...
Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) ...
Head and neck squamous cell carcinoma (HNSCC) ranks as one of the most common cancers globally, with over 650,000 new ...
A new study reveals how C210, a curcumin derivative, selectively reactivates Epstein–Barr virus to kill cancer cells without infectious risks, ...
A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, "Entering the golden age for ...
In a 10-center study, microwave ablation offered progression free survival rates and fewer complications than surgery in the treatment of ...
Announcing a new article publication for BIO Integration journal. Primary hepatic lymphoepithelioma-like carcinoma (LELC) is a malignant tumor with a ...
A new research paper was published in Genes & Cancer on February 5, 2023, entitled, "Mechanistically based blood proteomic markers ...
Programmed cell death 1 (PD-1) is an important target for immune checkpoint inhibitor therapies that block its signaling and boost ...
In a recent study published in JAMA Surgery, a group of researchers evaluated the safety and feasibility of a single-port ...
A recent International Journal of Obesity study explores the role of brain and muscle aryl hydrocarbon receptor nuclear translocator-like1 (BMAL1) in the ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net